QUIDELORTHO CORP Income (Loss) from Continuing Operations before Income Taxes, Domestic
QUIDELORTHO CORP (QDEL) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$523.80 million for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-19.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-02-19
- QUIDELORTHO CORP income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$523.80M.
- QUIDELORTHO CORP income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$2.17B.
- QUIDELORTHO CORP income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$163.90M, a 124.39% decline from fiscal 2023.
- QUIDELORTHO CORP income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was $672.10M, a 24.58% decline from fiscal 2022.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-28 | -$523.80M 10-K · filed 2026-02-19 |
| 2024-12-29 | -$2.17B 10-K · filed 2026-02-19 |
| 2023-12-31 | -$163.90M 10-K · filed 2026-02-19 |
| 2023-01-01 | $672.10M 10-K · filed 2025-02-27 |
| 2022-01-02 | $891.20M 10-K/A · filed 2024-08-01 |
| 2021-01-03 | $1.04B 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |